Xtant Medical Holdings, Inc.

Equities

XTNT

US98420P3082

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:10:00 2024-04-26 pm EDT 5-day change 1st Jan Change
0.95 USD +5.38% Intraday chart for Xtant Medical Holdings, Inc. +14.46% -15.93%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Xtant Medical Files $150 Million Mixed Shelf; Shares Fall MT
Transcript : Xtant Medical Holdings, Inc., Q4 2023 Earnings Call, Apr 01, 2024
Earnings Flash (XTNT) XTANT MEDICAL Reports Q4 Revenue $28.1M MT
Xtant Medical Holdings, Inc. Provides Earnings Guidance for the Full Year 2024 CI
Xtant Medical Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Xtant Medical Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
North American Morning Briefing : Stock Futures -2- DJ
North American Morning Briefing : Inflation Data -2- DJ
Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial CI
BTIG Starts Xtant Medical Holdings With Buy Rating, $2 Price Target MT
Xtant Medical Holdings Seeks M&A CI
Transcript : Xtant Medical Holdings, Inc., Q3 2023 Earnings Call, Nov 09, 2023
Xtant Medical Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Earnings Flash (XTNT) XTANT MEDICAL Reports Q3 Revenue $25M MT
Xtant Medical Holdings, Inc. Revises Earnings Guidance for the Year 2023 CI
North American Morning Briefing : Traders Await -2- DJ
Xtant Medical Holdings Buys nanOss Assets from RTI Surgical MT
Xtant Medical Holdings, Inc. acquired NanOss Production Operations of RTI Surgical, Inc. for $2.2 million. CI
Xtant Medical Closes Acquisition of Surgalign's Hardware, Biologics Business; Shares Surge After Hours MT
Xtant Medical Holdings, Inc. completed the acquisition of Certain assets from Surgalign Holdings, Inc.. CI
Transcript : Xtant Medical Holdings, Inc., Q2 2023 Earnings Call, Aug 01, 2023
Xtant Medical Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Earnings Flash (XTNT) XTANT MEDICAL Posts Q2 Revenue $20.2M MT
Xtant Medical Holdings, Inc. Raises Revenue Guidance for the Year 2023 CI
Xtant Medical Lands Surgalign Holdings' Hardware, Biologics Business in Auction MT
Chart Xtant Medical Holdings, Inc.
More charts
Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and its line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical Products, Thoracolumbar Products, Sacroiliac Joint Products, Interbody Products and Interlaminar Stabilization Products.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.95 USD
Average target price
1.925 USD
Spread / Average Target
+102.63%
Consensus
  1. Stock Market
  2. Equities
  3. XTNT Stock
  4. News Xtant Medical Holdings, Inc.
  5. Earnings Flash (XTNT) XTANT MEDICAL Posts Q1 Revenue $17.9M, vs. Street Est of $15.2M